Total Payments
$7,482
2024 Payments
$2,079
Companies
44
Transactions
305
Medicare Patients
687
Medicare Billing
$45,263
Payment Breakdown by Category
Food & Beverage$7,482 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,482 | 305 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,855 | 100 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $698.82 | 15 | $0 (2024) |
| Novo Nordisk Inc | $595.97 | 28 | $0 (2024) |
| Lilly USA, LLC | $533.78 | 35 | $0 (2023) |
| ORGANOGENESIS INC. | $409.24 | 6 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $380.10 | 20 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $363.89 | 16 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $246.41 | 10 | $0 (2023) |
| Inspire Medical Systems, Inc. | $159.38 | 2 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $153.54 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,079 | 78 | ABBVIE INC. ($522.38) |
| 2023 | $2,130 | 92 | ABBVIE INC. ($677.15) |
| 2022 | $1,502 | 74 | ABBVIE INC. ($286.21) |
| 2021 | $1,772 | 61 | ORGANOGENESIS INC. ($409.24) |
All Payment Transactions
305 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Neuroscience | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $2.33 | General |
| Category: Neuroscience | ||||||
| 11/26/2024 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 Marigen, Kerecis Omega3 Marigen | Food and Beverage | Cash or cash equivalent | $95.26 | General |
| Category: Wound Care | ||||||
| 11/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Gastroenterology | ||||||
| 11/14/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/06/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $135.39 | General |
| Category: Neuroscience | ||||||
| 11/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Obesity | ||||||
| 10/31/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $32.88 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.79 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.78 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.77 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Gastroenterology | ||||||
| 09/30/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $107.98 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Neuropsychiatry | ||||||
| 09/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $2.56 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.93 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.48 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $102.47 | General |
| Category: Obesity | ||||||
| 08/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 89 | 109 | $15,507 | $4,718 |
| 2022 | 2 | 108 | 142 | $23,842 | $7,368 |
| 2021 | 7 | 230 | 354 | $48,220 | $17,618 |
| 2020 | 7 | 260 | 382 | $42,389 | $15,559 |
Total Patients
687
Total Services
987
Medicare Billing
$45,263
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 66 | $10,245 | $2,986 | 29.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 25 | $4,917 | $1,560 | 31.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 14 | 18 | $345.00 | $171.36 | 49.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 86 | 116 | $18,096 | $5,801 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 26 | $5,746 | $1,567 | 27.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 62 | 76 | $16,544 | $5,583 | 33.7% |
| 11042 | Removal of skin and tissue first 20 sq cm or less | Facility | 2021 | 24 | 117 | $12,636 | $4,410 | 34.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 72 | 83 | $12,828 | $4,398 | 34.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 12 | 13 | $2,236 | $875.55 | 39.2% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 11 | 11 | $715.00 | $715.00 | 100.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 12 | 12 | $1,200 | $713.58 | 59.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 12 | 12 | $1,404 | $547.56 | 39.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 13 | 13 | $402.00 | $210.47 | 52.4% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 12 | 17 | $255.00 | $165.07 | 64.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 103 | 138 | $17,351 | $5,512 | 31.8% |
| 11042 | Removal of skin and tissue first 20 sq cm or less | Facility | 2020 | 23 | 95 | $10,260 | $3,668 | 35.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 40 | 46 | $8,510 | $2,954 | 34.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 26 | 26 | $2,600 | $1,180 | 45.4% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2020 | 19 | 19 | $1,235 | $1,159 | 93.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 11 | 15 | $1,335 | $522.65 | 39.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 23 | 23 | $798.00 | $369.29 | 46.3% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 15 | 20 | $300.00 | $193.25 | 64.4% |
About Mark Yoder, FNP-C
Mark Yoder, FNP-C is a Family healthcare provider based in Wooster, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2016. The National Provider Identifier (NPI) number assigned to this provider is 1235597048.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mark Yoder, FNP-C has received a total of $7,482 in payments from pharmaceutical and medical device companies, with $2,079 received in 2024. These payments were reported across 305 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($7,482).
As a Medicare-enrolled provider, Yoder has provided services to 687 Medicare beneficiaries, totaling 987 services with total Medicare billing of $45,263. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Wooster, OH
- Active Since 02/08/2016
- Last Updated 03/17/2018
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1235597048
Products in Payments
- VRAYLAR (Drug) $802.40
- UBRELVY (Drug) $733.99
- XIFAXAN (Drug) $347.20
- Wegovy (Drug) $301.37
- QULIPTA (Drug) $300.87
- SPRAVATO (Drug) $276.27
- MOUNJARO (Drug) $267.23
- BREZTRI (Drug) $264.55
- Puraply (Medical Supply) $262.79
- Kerendia (Drug) $246.41
- FARXIGA (Drug) $237.69
- NURTEC ODT (Drug) $167.06
- INSPIRE (Device) $159.38
- Puraply Antimicrobial (Medical Supply) $146.45
- Ozempic (Drug) $130.70
- Crysvita (Drug) $125.00
- REXULTI (Drug) $123.54
- AIRSUPRA (Drug) $110.00
- UZEDY (Drug) $109.28
- Auvelity (Drug) $107.98
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Wooster
Melissa Weygandt
Family — Payments: $15,248
Family $15,248
Christopher Mccourt
Family — Payments: $4,701
Family $4,701
Jessica Franklin, Np-C, NP-C
Family — Payments: $3,550
Family $3,550
Carolyn Graham, Np-C, NP-C
Family — Payments: $3,213
Family $3,213
Sara Daso, Np-C, NP-C
Family — Payments: $2,186
Family $2,186
Megan Anderson
Family — Payments: $1,912
Family $1,912